U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Demeclocycline – Oral products
  1. Development Resources

Demeclocycline – Oral products

FDA-Identified Interpretive Criteria

The following organisms that are susceptible to tetracycline are also considered susceptible to demeclocycline: Enterobacterales, Acinetobacter spp., Haemophilus influenzae, Neisseria gonorrhoeae, Staphylococcus aureus, Streptococcus pneumoniae (non-meningitis isolates), Bacillus anthracis and Franciscella tularensis

Back to Top